Paper 13300-39
Paper 13300-39
Seeing small and aiming big: the development and clinical impact of optical coherence tomography (Invited Paper)
26 January 2025 • 11:35 AM - 11:55 AM PST | Moscone South, Room 156 (Upper Mezz)
Abstract
Optical coherence tomography (OCT) is a technology invented in 1991 to image small critical tissue structures with micrometer resolution. It is widely used in eye and coronary heart diseases. I will tell the story of OCT’s initial conception from the inventor’s perspective along with an account of the rapid pace of development that made OCT a clinical reality. The biggest applications of OCT in the management of eye diseases will be shown. Recent advances that enable OCT to advance beyond the imaging of tissue structure to the detection of blood flow and photoreceptor function will be described.
Presenter
Casey Eye Institute (United States)
Dr. David Huang is the Associate Director and Director of Research of Casey Eye Institute, the Wold Family Endowed Chair in Ophthalmic Imaging, and Professor of Ophthalmology & Biomedical Engineering at the Oregon Health & Science University.
Dr. Huang is known for his innovations in applying laser and optical technology to eye diseases. He is a co-inventor of optical coherence tomography (OCT), a 3D high-resolution imaging technology used on patients more than 40 million times per year. His seminal article on OCT (Science 1991) has been cited more than 18,000 times. He has published over 350 peer-reviewed articles, 12 books, and 42 US patents. For his work on OCT technology and applications, Dr. Huang has been awarded the Lasker Award and the National Medal of Technology & Innovation.
Dr. Huang leads the Center for Ophthalmic Optics & Lasers (www.COOLLab.net). He is a founder of GoCheck, the maker of a smartphone app that has screened over 5 million children for eye diseases.